Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Toceranib> ?p ?o. }
Showing items 1 to 67 of
67
with 100 items per page.
- Toceranib abstract "Toceranib is a receptor tyrosine kinase inhibitor and is used in the treatment of canine mast cell tumor also called mastocytoma. Together with masitinib (Kinavet (US)/Masivet (EU/ROW) by AB Science), toceranib is the only dog-specific anti-cancer drug approved by the U.S. Food and Drug Administration. It is marketed as Palladia as its phosphate salt, toceranib phosphate (INN) by Pfizer. It was developed by SUGEN as SU11654, a sister compound to sunitinib, which was later approved for human therapies. Toceranib is likely to act mostly through inhibition of the kit tyrosine kinase, though it may also have an anti-angiogenic effect.".
- Toceranib atcPrefix "L01".
- Toceranib atcSuffix "XE91".
- Toceranib bioavailability "77.0".
- Toceranib casNumber "356068-94-5".
- Toceranib fdaUniiCode "59L7Y0530C".
- Toceranib iupacName "5-[(5Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide".
- Toceranib pubchem "8034466".
- Toceranib thumbnail Toceranib.svg?width=300.
- Toceranib wikiPageExternalLink www.palladia-pi.com.
- Toceranib wikiPageID "23088813".
- Toceranib wikiPageRevisionID "602083966".
- Toceranib atcPrefix "L01".
- Toceranib atcSuffix "XE91".
- Toceranib atcvet "yes".
- Toceranib bioavailability "77.0".
- Toceranib c "22".
- Toceranib casNumber "356068".
- Toceranib chemspiderid "4486268".
- Toceranib eliminationHalfLife "57600.0".
- Toceranib f "1".
- Toceranib h "25".
- Toceranib hasPhotoCollection Toceranib.
- Toceranib iupacName "5".
- Toceranib legalUs "Rx-only".
- Toceranib molecularWeight "396.46".
- Toceranib molecularWeight "494.46".
- Toceranib n "4".
- Toceranib o "2".
- Toceranib proteinBound "91".
- Toceranib pubchem "8034466".
- Toceranib routesOfAdministration "Oral".
- Toceranib smiles "Fc1ccc2c/C=C/c4cC".
- Toceranib tradename "Palladia".
- Toceranib unii "59".
- Toceranib subject Category:Amides.
- Toceranib subject Category:Dog_health.
- Toceranib subject Category:Indoles.
- Toceranib subject Category:Organofluorides.
- Toceranib subject Category:Pyrroles.
- Toceranib subject Category:Pyrrolidines.
- Toceranib subject Category:Receptor_tyrosine_kinase_inhibitors.
- Toceranib type Abstraction100002137.
- Toceranib type Amide114724264.
- Toceranib type Amides.
- Toceranib type Chemical114806838.
- Toceranib type Compound114818238.
- Toceranib type Material114580897.
- Toceranib type Matter100020827.
- Toceranib type OrganicCompound114727670.
- Toceranib type Part113809207.
- Toceranib type PhysicalEntity100001930.
- Toceranib type Relation100031921.
- Toceranib type Substance100019613.
- Toceranib type Drug.
- Toceranib type DrugProduct.
- Toceranib type FunctionalSubstance.
- Toceranib comment "Toceranib is a receptor tyrosine kinase inhibitor and is used in the treatment of canine mast cell tumor also called mastocytoma. Together with masitinib (Kinavet (US)/Masivet (EU/ROW) by AB Science), toceranib is the only dog-specific anti-cancer drug approved by the U.S. Food and Drug Administration. It is marketed as Palladia as its phosphate salt, toceranib phosphate (INN) by Pfizer.".
- Toceranib label "Toceranib".
- Toceranib sameAs m.064pn78.
- Toceranib sameAs Q7811972.
- Toceranib sameAs Q7811972.
- Toceranib sameAs Toceranib.
- Toceranib wasDerivedFrom Toceranib?oldid=602083966.
- Toceranib depiction Toceranib.svg.
- Toceranib homepage www.palladia-pi.com.
- Toceranib isPrimaryTopicOf Toceranib.